The biotechnology industry is rapidly evolving, with innovative companies pushing the boundaries of science and medicine. To ...

In a year that has seen an approval and a raft of readouts for metabolic dysfunction-associated steatohepatitis (MASH), ...

How supplies of GLP-1 drugs could be at risk as a result of the dockworker strike occurring across the East and Gulf coasts: ...

Vaccine biotech Gritstone bio is filing for bankruptcy while securing a stalking horse bid from an unnamed party, which the ...

Discover the top biotech companies pioneering the next healthcare breakthroughs. Learn how innovative firms are ...

Why Gilead cut a deal with 6 generics companies around a yet-to-be-approved, twice-a-year HIV PrEP drug: "It really is all ...

Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in September 2024.

A clinical trial of an experimental vaccine against Marburg virus has begun in Rwanda, where an outbreak has led to 49 cases ...

Nurix Therapeutics offers promising targeted protein degradation treatments for cancer and autoimmune diseases. Find out what ...

The pharmaceutical industry is promising due to AI and biotech innovations enhancing productivity, steady profits amidst ...

An LLC model in biotech brings specific advantages, such as streamlined deal-making, IP ownership, and capital reinvestment ...

Despite a 7% YTD gain, IBB ETF has underperformed the S&P 500, which is up 21%, and shows negative alpha. Read more on IBB ...